South Plainfield, New Jersey

PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2021 Financial Results

Retrieved on: 
Thursday, July 15, 2021

SOUTH PLAINFIELD, N.J., July 15, 2021 /PRNewswire/ --PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its second quarter 2021 financial results and provide an update on the company's business and outlook on Thursday, July 29, 2021, at 4:30 p.m. (ET) after the closing of the market.

Key Points: 
  • SOUTH PLAINFIELD, N.J., July 15, 2021 /PRNewswire/ --PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its second quarter 2021 financial results and provide an update on the company's business and outlook on Thursday, July 29, 2021, at 4:30 p.m. (ET) after the closing of the market.
  • The call can be accessed by dialing (877) 303-9216 (domestic) or (973) 935-8152 (international) five minutes prior to the start of the call and providing the passcode 7064479.
  • A live, listen-only webcast of the conference call can be accessed on the investor relations section of the PTC website at https://ir.ptcbio.com/events-presentations .
  • PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders.

De Rigo Debuts First Eyewear Collection For TUMI

Retrieved on: 
Thursday, July 1, 2021

NEW YORK, July 1, 2021 /PRNewswire/ -- De Rigo Group, one of the world's leading eyewear specialists is pleased to announce the launch of its first eyewear collection for TUMI, the premiere international travel, lifestyle and performance luxury brand.

Key Points: 
  • NEW YORK, July 1, 2021 /PRNewswire/ -- De Rigo Group, one of the world's leading eyewear specialists is pleased to announce the launch of its first eyewear collection for TUMI, the premiere international travel, lifestyle and performance luxury brand.
  • "It's been a pleasure working with TUMI to bring their eyewear collection to life.
  • The TUMI eyewear collection raises the bar for excellence when it comes to top performance, cutting-edge design, and best-in-class functionality.
  • It was developed at the intersection of fashion and function with the TUMI client top of mind," said Victor Sanz, Creative Director of TUMI.

Health and Human Services Expert Mary L. Smith Joins PTC Therapeutics' Board of Directors

Retrieved on: 
Wednesday, June 9, 2021

SOUTH PLAINFIELD, N.J., June 9, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the election of Mary L. Smith to the Company's Board of Directors.

Key Points: 
  • SOUTH PLAINFIELD, N.J., June 9, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the election of Mary L. Smith to the Company's Board of Directors.
  • "We are delighted to welcome Mary to PTC's Board of Directors," said Stuart W. Peltz, Ph.D., Chief Executive Officer of PTC Therapeutics.
  • Additionally, Ms. Smith founded the Caroline and Ora Smith Foundation, which sponsors, supports and trains Native American girls in science, technology, engineering and math.
  • To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, on Twitter at @PTCBio, and on LinkedIn.

TUMI Announces the Launch of their Professional Esports Collection

Retrieved on: 
Thursday, April 29, 2021

TUMIwantsthe equipmentathletes and hobbyistsrely ontosurvive every journey,whetherthat\'son the road,behind the deskor being cheered on byvirtual crowds.\nShowcasing TUMI\'s innovative nature, various components of this collection have been crafted with high-performance recycled materials.

Key Points: 
  • TUMIwantsthe equipmentathletes and hobbyistsrely ontosurvive every journey,whetherthat\'son the road,behind the deskor being cheered on byvirtual crowds.\nShowcasing TUMI\'s innovative nature, various components of this collection have been crafted with high-performance recycled materials.
  • Each piece is built to last, not only protecting the gear that matters most, but also the world\'s natural resources.
  • "\nSince 1975, TUMI has been creating world-class business, travel andperformanceluxury essentials, designed to upgrade, uncomplicate, and beautify all aspects of life on the move.
  • The brand is sold globally in over 75 countries with approximately 2,000 points of sale.\nView original content to download multimedia: http://www.prnewswire.com/news-releases/tumi-announces-the-launch-of-the...\n'

PTC Therapeutics to Participate at Upcoming Virtual Investor Conferences

Retrieved on: 
Tuesday, April 27, 2021

b"SOUTH PLAINFIELD, N.J., April 27, 2021 /PRNewswire/ --PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company overview at the following conferences:\nTuesday, May 11th at 8:45 a.m. ET\nTuesday, May 18th at 10:20 a.m. ET\nWednesday, May 26th at 12:00 p.m. ET\nThe presentations will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation.

Key Points: 
  • b"SOUTH PLAINFIELD, N.J., April 27, 2021 /PRNewswire/ --PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company overview at the following conferences:\nTuesday, May 11th at 8:45 a.m. ET\nTuesday, May 18th at 10:20 a.m. ET\nWednesday, May 26th at 12:00 p.m. ET\nThe presentations will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation.
  • It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.\nPTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders.
  • PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.
  • The Company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders.\nFOR MORE INFORMATION PLEASE CONTACT:\n"

PTC Therapeutics to Host Conference Call to Discuss First Quarter 2021 Financial Results

Retrieved on: 
Tuesday, April 20, 2021

b"SOUTH PLAINFIELD, N.J., April 20, 2021 /PRNewswire/ --PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its first quarter 2021 financial results and provide an update on the company's business and outlook on Tuesday, May 4, 2021 at 4:30 p.m. (ET) after the closing of the market.\nThe call can be accessed by dialing (877) 303-9216 (domestic) or (973) 935-8152 (international) five minutes prior to the start of the call and providing the passcode 4292410.

Key Points: 
  • b"SOUTH PLAINFIELD, N.J., April 20, 2021 /PRNewswire/ --PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its first quarter 2021 financial results and provide an update on the company's business and outlook on Tuesday, May 4, 2021 at 4:30 p.m. (ET) after the closing of the market.\nThe call can be accessed by dialing (877) 303-9216 (domestic) or (973) 935-8152 (international) five minutes prior to the start of the call and providing the passcode 4292410.
  • A live, listen-only webcast of the conference call can be accessed on the investor relations section of the PTC website at https://ir.ptcbio.com/events-presentations .A webcast replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days following the call.\nPTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders.
  • PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.
  • The Company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders.\nFOR MORE INFORMATION PLEASE CONTACT:\n"

PTC Therapeutics Received Gallup's "Don Clifton Strengths-Based Culture" Award

Retrieved on: 
Wednesday, April 7, 2021

SOUTH PLAINFIELD, N.J., April 7, 2021 /PRNewswire/ --PTC Therapeutics, Inc.(NASDAQ: PTCT) today announced that it has been named a winner of the 2021 "Don Clifton Strengths-Based Culture Award" from Gallup.

Key Points: 
  • SOUTH PLAINFIELD, N.J., April 7, 2021 /PRNewswire/ --PTC Therapeutics, Inc.(NASDAQ: PTCT) today announced that it has been named a winner of the 2021 "Don Clifton Strengths-Based Culture Award" from Gallup.
  • "We are honored to accept this award and appreciate the recognition that at PTC we have built an engaging and innovative work environment that is collaborative and committed to develop our employees," said Stuart W. Peltz, Ph.D., Chief Executive Officer of PTC Therapeutics.
  • To learn more about this award and see the full list of recipients, please visit the Don Clifton Strengths-Based Culture Award page.
  • To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, on Twitter at @PTCBio, and on LinkedIn.

PTC Therapeutics to Host PTC518 Huntington Disease Deep Dive Webinar

Retrieved on: 
Wednesday, April 7, 2021

SOUTH PLAINFIELD, N.J., April 7, 2021 /PRNewswire/ --PTC Therapeutics, Inc.(NASDAQ: PTCT) will host a webinar in its deep dive series discussing the PTC518 Huntington disease (HD) program on Thursday, April 15 at 9 a.m. E.T.

Key Points: 
  • SOUTH PLAINFIELD, N.J., April 7, 2021 /PRNewswire/ --PTC Therapeutics, Inc.(NASDAQ: PTCT) will host a webinar in its deep dive series discussing the PTC518 Huntington disease (HD) program on Thursday, April 15 at 9 a.m. E.T.
  • The Huntington Disease Deep Dive will provide an overview of PTC's splicing platform and the identification of molecules that have selectivity and specificity.
  • PTC will highlight its Huntington program and the potential advantages of an orally bioavailable compound.
  • PTC will discuss in detail the splicing modifier, PTC518, that is in an ongoing Phase 1 clinical trial.

TUMI unveils premium capsule luggage and travel collection inspired by McLaren

Retrieved on: 
Wednesday, March 31, 2021

From automotive to sports, TUMI is inspired by the world's most innovative industries.

Key Points: 
  • From automotive to sports, TUMI is inspired by the world's most innovative industries.
  • The two brands share the common vision of continually pursuing higher levels of excellence, which is reflected in the considered details and choice of materials in the McLaren inspired TUMI range.
  • Embodying TUMI and McLaren's mutual ethos of performance luxury, the capsule collection is comprised of nine pieces.
  • The collection will be available 31 March 2021 via TUMI.com, TUMI's Global retail stores, McLarenstore.com, and select McLaren retailers Globally.

TUMI unveils premium capsule luggage and travel collection inspired by McLaren

Retrieved on: 
Wednesday, March 31, 2021

From automotive to sports, TUMI is inspired by the world's most innovative industries.

Key Points: 
  • From automotive to sports, TUMI is inspired by the world's most innovative industries.
  • The two brands share the common vision of continually pursuing higher levels of excellence, which is reflected in the considered details and choice of materials in the McLaren inspired TUMI range.
  • Embodying TUMI and McLaren's mutual ethos of performance luxury, the capsule collection is comprised of nine pieces.
  • The collection will be available 31 March 2021 via TUMI.com, TUMI's Global retail stores, McLarenstore.com, and select McLaren retailers Globally.